• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本年轻女性宫颈癌风险的差异:HPV疫苗接种与癌症筛查的两极分化状况

Disparity of Cervical Cancer Risk in Young Japanese Women: Bipolarized Status of HPV Vaccination and Cancer Screening.

作者信息

Taniguchi Mariko, Ueda Yutaka, Yagi Asami, Miyoshi Ai, Tanaka Yusuke, Minekawa Ryoko, Endo Masayuki, Tomimatsu Takuji, Hirai Kei, Nakayama Tomio, Kimura Tadashi

机构信息

Department of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan.

Department of Obstetrics and Gynecology, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Sakai 591-8025, Osaka, Japan.

出版信息

Vaccines (Basel). 2021 Mar 19;9(3):280. doi: 10.3390/vaccines9030280.

DOI:10.3390/vaccines9030280
PMID:33808630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8003385/
Abstract

Women born between 1994 and 1999 achieved high vaccination rates for human papillomavirus (HPV); they are now reaching the age of cervical cancer screening programs in Japan. In this study, we aimed to investigate the health awareness of HPV-vaccinated and unvaccinated women and to create tailored leaflets recommending cervical cancer screening for each. Surveys on the cancer screening rates for HPV-vaccinated and unvaccinated women aged 20 and 21 have demonstrated that the rate was significantly higher ( < 0.01) in vaccinated (6.2%) than in unvaccinated women (3.1%). Next, interviews and Internet questionnaires clarified that there was a trend that vaccinated women have a better health consciousness than the unvaccinated ones, and that in unvaccinated women, their willingness to receive cervical cancer screening was significantly enhanced by the fear of developing cancer. Finally, in a prospective study, the increase in the screening rate for both vaccinated and unvaccinated groups after they read tailored leaflets, from 6.4% to 7.4% and from 3.9% to 5.1%, respectively, was not statistically significant compared to the groups provided with a standard reminder letter. Cervical cancer control measures might be enhanced by recommending cervical cancer screening in ways better tailored to HPV vaccination status.

摘要

1994年至1999年出生的女性实现了较高的人乳头瘤病毒(HPV)疫苗接种率;她们现在正步入日本宫颈癌筛查项目的年龄阶段。在本研究中,我们旨在调查接种HPV疫苗和未接种HPV疫苗的女性的健康意识,并为她们分别制作针对性的宫颈癌筛查推荐传单。对20岁和21岁接种HPV疫苗和未接种HPV疫苗的女性的癌症筛查率调查表明,接种疫苗者(6.2%)的筛查率显著高于未接种疫苗者(3.1%)(<0.01)。接下来,通过访谈和网络问卷明确,接种疫苗的女性比未接种疫苗的女性有更好的健康意识这一趋势,并且在未接种疫苗的女性中,她们对患癌的恐惧显著增强了接受宫颈癌筛查的意愿。最后,在一项前瞻性研究中,接种疫苗组和未接种疫苗组在阅读针对性传单后的筛查率分别从6.4%提高到7.4%和从3.9%提高到5.1%,与收到标准提醒信的组相比,差异无统计学意义。通过以更适合HPV疫苗接种状况的方式推荐宫颈癌筛查,可能会加强宫颈癌控制措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c4/8003385/74d3a0f4be26/vaccines-09-00280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c4/8003385/74d3a0f4be26/vaccines-09-00280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c4/8003385/74d3a0f4be26/vaccines-09-00280-g001.jpg

相似文献

1
Disparity of Cervical Cancer Risk in Young Japanese Women: Bipolarized Status of HPV Vaccination and Cancer Screening.日本年轻女性宫颈癌风险的差异:HPV疫苗接种与癌症筛查的两极分化状况
Vaccines (Basel). 2021 Mar 19;9(3):280. doi: 10.3390/vaccines9030280.
2
How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.人乳头瘤病毒(HPV)疫苗接种状况与风险认知及参与宫颈癌筛查的意愿有何关系?一项调查研究。
BMC Public Health. 2016 Aug 3;15:708. doi: 10.1186/s12889-016-3397-y.
3
Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.宫颈癌筛查率因 HPV 疫苗接种状况而异:一项中期分析。
Vaccine. 2019 Jul 26;37(32):4424-4426. doi: 10.1016/j.vaccine.2019.06.064. Epub 2019 Jul 2.
4
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.细胞学检测向 HPV 检测转变将如何改变宫颈癌筛查的获益与危害平衡?对澳大利亚(高疫苗接种率国家)宫颈癌、治疗率和不良产科结局影响的评估。
Int J Cancer. 2017 Dec 15;141(12):2410-2422. doi: 10.1002/ijc.30926. Epub 2017 Oct 5.
5
Exacerbating disparities?: Cervical cancer screening and HPV vaccination.加剧差距?:宫颈癌筛查和 HPV 疫苗接种。
Prev Med. 2020 Jan;130:105902. doi: 10.1016/j.ypmed.2019.105902. Epub 2019 Nov 12.
6
Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.在人乳头瘤病毒疫苗接种背景下,初级保健医生对宫颈癌筛查和预防专家建议的遵循情况。
Sex Transm Dis. 2016 Jul;43(7):438-44. doi: 10.1097/OLQ.0000000000000458.
7
Non-Adherence To Childhood HPV Vaccination Is Associated With Non-Participation In Cervical Cancer Screening A Nationwide Danish Register-Based Cohort Study.儿童人乳头瘤病毒疫苗接种不依从与子宫颈癌筛查未参与情况相关:一项基于丹麦全国登记的队列研究
Clin Epidemiol. 2019 Nov 8;11:969-980. doi: 10.2147/CLEP.S203023. eCollection 2019.
8
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.部分接种人乳头瘤病毒疫苗队列中的宫颈癌筛查——一项成本效益分析
PLoS One. 2016 Jan 29;11(1):e0145548. doi: 10.1371/journal.pone.0145548. eCollection 2016.
9
Internet Survey of Awareness and Behavior Related to HPV Vaccination in Japan.日本HPV疫苗接种相关认知与行为的网络调查
Vaccines (Basel). 2021 Jan 25;9(2):87. doi: 10.3390/vaccines9020087.
10
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.澳大利亚 HPV 疫苗接种和未接种女性中基于 HPV 的细胞学筛查与初级 HPV 检测的比较:国家宫颈癌筛查计划的有效性和经济评估。
Lancet Public Health. 2017 Feb;2(2):e96-e107. doi: 10.1016/S2468-2667(17)30007-5. Epub 2017 Feb 7.

引用本文的文献

1
Vaccine Confidence and Coverage among Medical Students at a Federal University in Brazil.巴西一所联邦大学医学生的疫苗信心和接种率
Vaccines (Basel). 2024 Aug 30;12(9):993. doi: 10.3390/vaccines12090993.
2
A transversal cross-sectional study of factors related to HPV vaccination status and cancer screening participation among French women aged 25-40.一项关于与 HPV 疫苗接种状况和法国 25-40 岁女性癌症筛查参与度相关因素的横断面研究。
BMC Cancer. 2024 Jul 6;24(1):807. doi: 10.1186/s12885-024-12591-1.
3
Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.

本文引用的文献

1
HPV Vaccination and the Risk of Invasive Cervical Cancer.HPV 疫苗接种与浸润性宫颈癌风险。
N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
2
Potential for cervical cancer incidence and death resulting from Japan's current policy of prolonged suspension of its governmental recommendation of the HPV vaccine.由于日本目前长期暂停政府推荐 HPV 疫苗接种的政策,可能导致宫颈癌发病率和死亡率上升。
Sci Rep. 2020 Sep 29;10(1):15945. doi: 10.1038/s41598-020-73106-z.
3
Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
人乳头瘤病毒疫苗对日本浸润性宫颈癌的影响:癌症统计数据和 MINT 研究的初步结果。
Cancer Sci. 2023 Nov;114(11):4426-4432. doi: 10.1111/cas.15943. Epub 2023 Sep 8.
4
Impact of the Threat of COVID-19 Infections on the Perceived Risk to HPV Vaccination.新冠病毒感染威胁对人乳头瘤病毒疫苗接种感知风险的影响
Vaccines (Basel). 2022 May 23;10(5):829. doi: 10.3390/vaccines10050829.
5
Educational intervention for women in Japan coming of age for cervical cancer screening who grew up during the suspended HPV-vaccination-program.针对在人乳头瘤病毒疫苗接种计划暂停期间成长起来、现已到宫颈癌筛查年龄的日本女性的教育干预措施。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4418-4422. doi: 10.1080/21645515.2021.1950503.
6
Challenges and Perspectives for Prevention of Infectious Diseases.传染病预防的挑战与展望
Vaccines (Basel). 2021 Jun 1;9(6):571. doi: 10.3390/vaccines9060571.
日本各财政年度的人乳头瘤病毒(HPV)疫苗校正接种率。
Cancer Sci. 2020 Jun;111(6):2156-2162. doi: 10.1111/cas.14406. Epub 2020 Apr 27.
4
Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.宫颈癌筛查率因 HPV 疫苗接种状况而异:一项中期分析。
Vaccine. 2019 Jul 26;37(32):4424-4426. doi: 10.1016/j.vaccine.2019.06.064. Epub 2019 Jul 2.
5
HPV vaccination in Japan: what is happening in Japan?日本的人乳头瘤病毒疫苗接种情况:日本正在发生什么?
Expert Rev Vaccines. 2019 Apr;18(4):323-325. doi: 10.1080/14760584.2019.1584040. Epub 2019 Feb 22.
6
Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry.基于人群的大阪癌症登记处的宫颈癌流行病学和临床分析。
Cancer Res. 2019 Mar 15;79(6):1252-1259. doi: 10.1158/0008-5472.CAN-18-3109. Epub 2019 Jan 11.
7
Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan.人乳头瘤病毒单一类型感染作为日本高级别宫颈上皮内瘤变和浸润癌病因的研究
Papillomavirus Res. 2018 Dec;6:46-51. doi: 10.1016/j.pvr.2018.10.001. Epub 2018 Oct 26.
8
The projected timeframe until cervical cancer elimination in Australia: a modelling study.澳大利亚消除宫颈癌的预计时间框架:建模研究。
Lancet Public Health. 2019 Jan;4(1):e19-e27. doi: 10.1016/S2468-2667(18)30183-X. Epub 2018 Oct 2.
9
Differential misclassification between self-reported status and official HPV vaccination records in Japan: Implications for evaluating vaccine safety and effectiveness.日本自我报告状态与官方HPV疫苗接种记录之间的差异误分类:对评估疫苗安全性和有效性的影响。
Papillomavirus Res. 2018 Dec;6:6-10. doi: 10.1016/j.pvr.2018.05.002. Epub 2018 May 25.
10
Vaccination protects against invasive HPV-associated cancers.接种疫苗可预防与HPV相关的侵袭性癌症。
Int J Cancer. 2018 May 15;142(10):2186-2187. doi: 10.1002/ijc.31231. Epub 2018 Jan 4.